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1. Introduction
  Nonunion induced by oral and maxillofacial tumors or 
bone defects caused by trauma pose a difficult problem for 
clinical bone repair at present. Currently, it is a hotspot to 
study bone repair using tissue engineering bones to repair 
various kinds of bone defects and nonunion. Growth factors 
have been confirmed to play an important role in the process 
of repairing bone defects using tissue engineering bones. By 
compositing appropriate bone growth factors osteoinduction 
and osteogenesis process can be promoted so as to obtain a 
good effect of bone defect repair. Recombinant human bone 
morphogenetic protein-2 (rhBMP-2) is an important bone 
growth factor existing in bone matrix. It has been proven 
to possess an obvious activity in inducing osteogenesis, 
specifically motivating the directional differentiation of 
cells, stimulating mesenchymal cells and the precursor cells 
in bone marrow directionally differentiate into cartilage 
cells and osteoblast and accelerating the regeneration 
of bone tissue and repair process. However, no research 
has been done to study the effect of sustained-release of 
rhBMP-2 on the whole osteogenesis process. The present 
study aimed to study the effect of rhBMP-2 sustained-
release nanocapsules wraped by chitosan nanoparticles 
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on the whole process of ectopia osteogenesis in peroneal 
muscle pouches in rats, and to provide experimental basis 
for further studies on materials composited by rhBMP-2 and 
tissue-engineered bone.
2. Materials and methods
2.1. Animals and materials
   Kunming Sprague-Dawley (SD) rats weighing 20 to 24 g
were provided by Laboratory Animal Center,  Sun Yat-
Sen University, Nanjing (License No. SCXK (YUE) 2011-
0029). The rhBMP-2 and collagen-1 were provided by the 
Biological Engineering Research Institute, Jinan University, 
Guangdong, China. 
2.2. Experimental protocol
2.2.1. Preparation of composite materials
   0.01 mol/L PBS solution, collagen-1 solution, 0.4 mg/
mL rhBMP-2 solution and 4 mg/mL chitosan were used to 
prepare different solutions in terms of different dosages in 
different groups. That is Group B (only treated with collagen): 
4 810 毺L collagen solution+390 毺L PBS solution; Group C 
(rhBMP-2+collagen): 4 810 毺L collagen solution+130 毺L 
rhBMP-2 solution+260 毺L  PBS solution; Group D (rhBMP-2/
cs+collagen): 4 810 毺L collagen solution+130 毺L rhBMP-2 
solution+130 毺L chitosan solution+260 毺L PBS solution. 
The above solutions for each group were added into 96-well 
plate with 12 wells for each group and 400 毺L solution for 
each well. The plate was freeze-died in the lyophilizer and 
sterilized at 60 曟 for further use.
2.2.2. Animal model
   Twenty four Kuming SD rats were kept in cages separately 
at room temperature with free access to water. They were 
allowed to acclimatize for one week. The rats were randomly 
divided into 4 groups with 6 rats in each group and treated 
with different composite materials. Group A served as blank 
control, Group B was only treated with collagen, Group C 
was treated with rhBMP-2+collagen and Group D treated 
with rhBMP-2/cs+collagen. The rats were anaesthetized 
by intraperitoneal injection of 2% pentobarbital solution. 
Their skins at inner side of peroneus on both sides of rats 
were preserved, sterilized and incised. The intermuscular 
spaces were bluntly dissected to expose the muscle pouches 
of peroneus. Then the prepared composite materials were 
implanted into muscle pouches and the skins were sutured. 
The intermuscular spaces of rats in control group were only 
separated without implanting any materials. Each rat was 
kept in a separate  cage.
2.2.3. General observation and sampling
   The status of daily activities, feeding and wound healing 
was observed after operation. The rats in each group were 
successively sacrificed 2 weeks and 4 weeks post treatment. 
The parts of peroneus implanted with different drugs were 
cut off for sampling and then fixed in 10% neutral formalin 
buffer for further study. 
2.2.4. Micro-CT scan
   The resected samples were detected with Micro-
CT (ZKKS-MCT-Sharp, Guangzhou Zhongke Kaisheng 
Medical Technology Co., Ltd) and the bone parameters 
were measured and analized. The scan parameters were 
scanning resolution 20毺m; rotation angle 360曘; rotation 
angle increment 0.72曘; voltage  70 kv; power 40 W; 
average of frames 2; inter-layer spacing 20 毺m. The 
obtained CT images were transferred into three dimensional 
reconstructed images by bundled software of ZKKS MCT-
Sharp. The regions of interest (ROI) (size 0.5 mm×0.5 mm×0.2 
mm) were selected for observation of the effect of bone 
formation. The following bone parameters were analyzed: 1. 
bone volume fraction (BVF) refers to the ratio of the volume 
of bony structure and the total volume of samples, namely 
the ratio (%) of mineralized tissue; 2. Tb. Th refers to the 
average thickness of the bone trabeculas (毺m); and 3. Bone 
mineral density (BMD, mg/cc) .
2.2.5. Histological observation
   The samples that was fixed by the formalin buffer were 
dyed with HE and the The histologic morphology of samples 
in each group were observed under inverted microscope.
2.3. Statistical analysis
   All the data were presented as mean  and SPSS 13.0 
statistic package software was used for t test analysis. 
Differences were considered as statistically significant if 
P<0.05 and as significantly different if P<0.01.
3. Results
3.1. General observation
   Animals of each group were fed under standard condition 
after operation. Each rat was kept in a separate cage to avoid 
non-experimental death due to attack between animals, 
leading to the termination of the experiment. All the rats 
revived on the day of treatment with reduced activities and 
feedings which returned to normal 1 to 2 day post treatment. 
All wounds at hind legs of the rats were primary healing, 
without swelling and exudation. Sutures fell off 5 to 7 days 
postoperatively.  Weights of rats increased slowly and their 
activities and feeding were active. 
3.2. Micro - CT scan and 3D reconstruction
   Micro-CT scan showed no ectopia osteogenesis in group 
A (blank control group) and group B (collagen group), while 
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new bone formation could be observed in both Group C 
(rhBMP-2 + collagen) and Group D (rhBMP -2/cs + collagen). 
The bones were in irregular shape or long spindle shape. 
The gray level was obviously lower in the new formed bones 
than that in normal bones. The outer layers of the newly 
formed bones were surrounded by continuous cartilage-like 
sclerotin which discontinuously stretched into the center 
of caudomedial part, forming a loose bone trabecular-like 
structure. The 3D reconstruction images of groups C and D 
are presented in Figure 1. The osteogenesis effect in Group 
C was better than that of group D at the second week, while 
this effect is better in Group D than that of Group C at the 
fourth week. Little changes of osteogenesis was observed in 
Group C at the second and fourth week, while osteogenesis 
effect at the fourth week in Group D is obviously better than 
that at the second week.
Figure 1. Micro-CT three dimensional reconstructed image of the 
bones of four groups.
A: Micro-CT image of Group C at the second week;
B: Micro-CT image of Group D at the second week;
C: Micro-CT image of Group C at the fourth week;
D: Micro-CT image of Group D at the fourth week.
3.3. Analysis of Micro-CT bone parameters 
   Among the bone parameters obtained in Micro-CT, BVF 
refers to the ratio of the volume of bony structure and 
the total volume of samples. A greater value represents 
more content of the bone trabeculas. Tb. Th refers to the 
average thickness of the bone trabeculas, and a greater 
value shows solider trabecular bone structures and a better 
osteogenesis effect. BMD represents the density of the whole 
bone minerals. A greater value suggests a greater amount 
of new bone formation. Because no ectopia osteogenesis 
was observed in Group A and B in Micro-CT scan, bone 
parameter analysis was performed only in the regenerated 
bones in Group C and D. The middle regions of cartilage-
like bones of the outer layer of regenerated bones were 
selected as ROI. The results are shown in Table 1. 
Table 1




Group C (2nd week) 73.51±3.67 127.40±16.55 281.32±15.19
Group D (4th week) 54.05±1.26書   95.33±11.84書 207.10±14.82書書
Group C (2nd week) 81.69±4.45 135.33±17.84 294.33±13.97





書P<0.05,書書P<0.01,vs Group C(2w), 吤P<0.05, 吤吤P<0.01,vs Group 
D(2w),*P<0.05, **P<0.01,vs Group C(4w).
   BVF values in Group C were higher than that in Group D 
(P<0.05) at the second week, while BVF values in Group D 
were higher than that in group C (P<0.05) at the fourth week. 
There is no significant difference (P>0.05) between the BVF 
values at the fourth week and that at the second week in 
group C, while BVF value in Group D is significantly higher 
(P<0.01) at the fourth week compared to the values at the 
second week, indicating that the BMD value in Group D is 
maximum at the fourth week.
3.4. Histological observation 
   No inflammation or fiber cells infiltrations caused by 
trauma were observed in muscle tissues of Group A (control 
group) (Figure 2A). No new bone formation or obvious drug 
residues was observed in Group B (collagen treated group) 
within the tissue section, while invasion of a few fiber cells 
can be seen in the muscle tissues and mesenchymal tissues 
(Figure 2B). Ectopic bone formations could be observed in 
Group C at the second week, with clear boundaries between 
the tissues and the surrounding muscle tissues. The edges 
of the regenerated bones are surrounded by a circle of thin 
layer of continuous cartilage-like bone. Most of the cells in 
bone matrix are present as individual existence, cartilage 
lacunas are obvious. Scattered discontinuous bone could be 
seen in the ectopic regenerated bone, and a few capillary 
lumens and scattered erythrocytes are observed around the 
bone matrix (Figure 2C). Ectopic regenerated bones were 
observed in Group D, the thin layers of continuous cartilage-
like bones around the regenerated bones are obviously 
reduced compared with Group C. The cells within the bone 
matrix exist in the form of single cartilage-like cells with 
unobvious cartilage lacunas (Figure 2D). The structures 
of the ectopic regenerated bones at the fourth week were 
similar to that at the second week in Group C, with the edges 
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of the regenerated bones surrounded by a circle of thin layer 
of continuous cartilage-like bones and most of the cells in 
bone matrix present as individual existence with obvious 
cartilage lacunas (Figure 2E). There is an obvious increase 
of continuous bone substance formations in the regenerated 
bones in Group D compared with that at the second week. 
The cells inside the bone matrix exist in a form of collective 
cartilage-like cells and the cartilage lacunas are more clear 
than that in Group C at the fourth week (Figure 2F).
C                                                                      D
E                                                                      F
A                                                                      B
Figure 2. Histological results.
A: Group A (HE, 暳100); B: Group B (HE, 暳100); C: Group C at 2nd 
week (HE, 暳100); D: Group D at 2nd week (HE, 暳100); E: Group C at 
4nd week (HE, 暳100); F: Group D at 4nd week (HE, 暳100)
4. Discussion
   There is a good prospect of clinical application in using 
tissue engineering methods to repair bone defect. Among 
the studies in this field, the composite of bioactive factors 
is another research hot spot in the application of bone 
tissue engineering. There are many known types of bone 
growth factors, among which bone morphogenetic proteins 
(BMP) is very effective on inducing osteogenesis. It can 
specifically induce directional differentiation of the cells, 
stimulate the directional differentiation of mesenchymal 
cells and precursor cells in bone marrow into cartilage 
cells and osteoblasts and accelerate the repair and 
regeneration process of bone tissue[1]. In the family of 
BMPs, BMP-2 is one of the most effective bone growth 
factors in inducing osteogenesis. However, due to the 
limited body content of endogenous BMP, there is a need to 
add exogenous rhBMP-2. rhBMP-2 can induce irreversible 
differentiation of undifferentiated mesenchymal cells into 
cartilage cells and osteoblasts, promote the proliferation 
and differentiation of osteoblasts and fibroblasts, thereby 
inducing the synthesis of bone matrix and motivating new 
bone formation. rhBMP-2 has no species specificity, it has 
the ability to induce new bone formation across species. It 
has been proven in many studies that rhBMP-2 is highly 
effective in inducing osteogenetic activities[1-7]. Yoneda, 
et al[8]found that BMPs was effective enough in bone 
regeneration to repair bone tissues in scaffold materials. 
A previous study showed that BMP-2 could promote bone 
repair in PLGA/Hap scaffolds[9]. In a study by Wodewotzky 
et al[10], it has been found that after being implanted into 
bodies of dogs, rhBMP-2 was gradually released along 
with the degradation of PDLLA, stimulated and induced 
the differentiation and osteogenesis around the nail paths 
and the end of broken bones, effectively assisting the 
healing of the nail paths. Wildemann et al[11]studied the 
effect of combining BMP-2 and PDLLA on delayed union 
of fracture in animal models. Compared with PDLLA group, 
there was a significant increase in mechanical stability 
in BMP-2 and PDLLA composite group, suggesting that 
regional application of BMP-2 can stimulate the recovery 
of delayed union of fracture. A study by Tong et al[12]has 
shown that composition of PDLLA and BMP was effective 
in repairing bone defects. It induced the appearance of 
new bone formation with the degradation of composite 
materials. The results of the present study also confirmed 
that the ectopic osteogenesis could be observed when 
rhBMP-2 was applied alone, which proved rhBMP-2 can 
alone induce the differentiation of mesenchymal cells into 
cartilage cells and osteoblasts in muscle tissues, forming 
new bone matrix.
   The main biological function of BMP is to induce the 
differentiation of undifferentiated mesenchymal cells into 
cartilages and bones. However, a regional and alone use of 
BMP did not show a satisfying treatment effect, for which 
the main reason was the polypeptide growth factors was 
diluted, resolved and absorbed regionally in a short period 
and it could not effectively stimulate the target cells for 
long[13].
   Precursor chitin of chitosan[14]is the main structural 
polysaccharide in the arthropod keratin. It can interact 
with matrix proteins and connective tissue components. 
Chitosan is the product of a partial deacetylation of chitin, 
so it multiply reacts with the body tissues in the inner 
environment. Chitosan is positively charged, which induces 
the PH responsive electrostatic interactions between 
chitosan and anion glycosaminoglycan, proteoglycan 
and other negatively charged macromolecular, making 
these components retain and gather in the stent in the 
cell culture or after implanted in the body. Studies 
have shown that growth factors usually combine with 
Ren-Fa Lai et al./Asian Pacific Journal of Tropical Medicine (2013)884-888888
glycosaminoglycans which mediate the effect of growth 
factors. Chitosan-based biomaterial scaffolds will collect 
required growth factors from the surrounding tissue fluid. 
In addition, chitosan is a natural extracted product and 
it has a good biological compatibility and adaptability 
without any antagonism effect to human body, so it is often 
used as a modifying polymer on the surface of materials[15]. 
In the present study chitosan nanoparticles was used to 
wrap rhBMP-2 so as to realize the slow release of rhBMP-2 
and continuously work in the whole process of ectopia 
osteogenesis.
   The results of the present study showed that at the 
second week, the effect of ectopia osteogenesis was better 
in rhBMP-2 burst-release group than that in rhBMP-2 
slow-release group, for which the reason may be the 
incompletely release of rhBMP-2 in slow-release group in 
2 weeks time and the function of ectopia osteogenesis of 
rhBMP - 2 was not fully effected. While at the fourth week, 
the effect of rhBMP-2 slow-release group was significantly 
better than that of rhBMP-2 burst-release group, for which 
the possible reason was rhBMP-2 has been completely 
released and it quickly worked to induce bone formation 
in burst-release group by the end of the second week. This 
is why the osteogenesis effect of rhBMP-2 burst-release 
group showed nearly no difference betweem the second 
week and the fourth week. As there were no chitosan 
nanoparticles to control the slow-release in rhBMP-2 
burst-release group, rhBMP–2 was immediately released 
after contact with body fluids, presenting its effect at the 
early stages of osteogenesis. However, at the later stages 
of osteogenesis rhBMP-2 has been completely released, 
showed no effect of promoting bone formation. On the 
contrary, the ectopic osteogenesis effect in RhBMP-2 slow-
release group was much better at the fourth week than that 
at the second week, which proved that the slow release of 
rhBMP-2 ensured rhBMP-2 release in the whole ectopic 
osteogenesis process, thus maximize its effect on new bone 
formation.
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